Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
about
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidLong-acting beta2-agonists for stable chronic asthmaStriving for optimal bronchodilation: focus on olodaterolCircadian rhythms in the pharmacokinetics and clinical effects of beta-agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma.Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterolLong-acting inhaled beta(2)-agonist therapy in asthma.Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness.A comparison of the effect of salmeterol and salbutamol in normal subjects.Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lungCase-control study of salmeterol and near-fatal attacks of asthma.Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonistInteraction and dose equivalence of salbutamol and salmeterol in patients with asthmaInhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.Drugs for asthmaPulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsPrevention of exercise induced asthma by inhaled salmeterol xinafoate.Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.Long-acting beta 2-agonists. Role in primary care asthma treatment.Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways diseaseThe 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.Systemic effects of salbutamol and salmeterol in patients with asthma.Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study GroupBreathing during sleep in patients with obstructive lung disease.Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.Beta-Adrenergic AgonistsLack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.Comprehensive asthma management: guidelines for clinicians.A one-week dose-ranging study of inhaled salmeterol in children with asthma.Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Sir David Jack: an extraordinary drug discoverer and developer.Tolerance with beta 2-adrenoceptor agonists: time for reappraisal.Salmeterol: a novel, long-acting beta 2-agonist.Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
P2860
Q24246441-118589AF-0BA9-44CD-B073-334D04F4FC06Q24247926-E5C74EDF-051B-4358-82D9-8B6742C79440Q26752887-66623F1D-3318-4193-A08B-C822DB5DDCFEQ33747962-DC73643F-DBBD-48D4-8370-3591CE89C398Q33775366-30BB1369-15E2-4BA9-B491-4B1860939182Q34392656-15122A7B-FB6D-43F4-8CB9-6232B3777A21Q34402775-B5A48457-6468-4A0C-91D8-E2EF27A61664Q34402874-F2BEB772-26A1-4EF9-B870-2FEE3FC2CCF7Q34574302-78F45E9A-D5FD-4C7E-9814-D23B4A7D57BEQ34747095-51BF20D6-0D4D-486E-9784-2457C3622D2CQ35171854-FD4FA2D5-E804-4CC5-9B6C-56F2AEAA8C19Q35187262-114C6F6C-FB25-4481-B7B0-A7D124B4AE78Q35252017-4F5572B2-86C5-42FF-B248-AE6234F72B6CQ35533937-05A30CB8-350B-45BA-AE65-7ABBE5FE5DE8Q35563253-11208A74-DAE3-4514-9BC4-9C94B4B59213Q35566594-1C464807-09F0-46FF-B076-6D94D671C710Q35583186-54284275-BA96-41F2-86E6-B5E799F4276EQ35627764-B379802C-DB5A-4A43-9282-1BD5C1F015F0Q35627925-F1EB1802-65A6-429F-9185-C9FEBA1D4884Q35871413-007D2957-C2A4-47D6-AA41-F454A7C77EE0Q35873966-4F076C22-3E45-47A0-8FDA-2449801EBC33Q36280784-DB6E24B0-2C61-4B4E-A78C-34EC3F6BD755Q36479702-319C13CA-4AF0-4183-AB8C-FDE6915642A1Q36496223-678C9580-D1AD-4B3B-8BF7-5443AC7C7530Q36516893-C6D83EAD-090D-4D72-80F3-BB90BA6A4FF2Q36559591-52E5C99E-E090-4FDB-BAFC-B97169984CF1Q36573494-375DED67-BDFC-429F-BD6B-57C6C3BF098DQ36576295-4EE9F79F-13CE-47A1-86BF-211A5ABC164EQ37916214-38902079-18FE-4913-841D-2041B0D9B39DQ38234940-7BBC8840-5740-472A-8E82-6F4D9B59CA5BQ38974241-AB53B31A-2FDA-418E-BD13-33ED0C7723C5Q39439356-54D9EBF5-F1A4-4D86-A753-36329C0FFE79Q39442838-0B5857CD-82BD-418A-93AF-B10F6330785AQ39459568-5D26D414-4EF4-4DFB-8619-EA4B7CB20618Q39914397-BFD79046-7014-49F2-8308-A236011BEE91Q40086536-DC68D7B9-EF0D-4D17-A94E-BA0542EFE3D2Q40520444-D3E4BA4D-05EC-456F-A48B-82BE62A7B711Q40620716-4BA1D40B-FF70-4A66-8B76-4C990117F49DQ40713319-9CD97331-BD31-4185-B38F-1BF3DF5CF32AQ41525081-C734AB52-FDED-44A6-8B26-B1799F02B692
P2860
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@ast
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@en
type
label
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@ast
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@en
prefLabel
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@ast
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@en
P2860
P356
P1433
P1476
Salmeterol, a new long acting ...... l in adult asthmatic patients.
@en
P2093
P2860
P304
P356
10.1136/THX.43.9.674
P407
P577
1988-09-01T00:00:00Z